Conservative Treatment of Patients With Temporomandibular Disorders

All patients will be offered the self-care checklist of homecare approaches at baseline. Patients will be treated for two months with follow up at 3 and 6 months after enrollment. The primary outcome measure will be an 11 point Numerical Rating Scale for average TMD pain during the past week. Secondary outcomes will include the Oral Health Impact Profile (OHIP-14), believability of the sham AMCT compared to active AMCT, expectations of and satisfaction with care, medication use, bothersomeness of symptoms and health care utilization. Our project is a collaborative effort between the Palmer Center for Chiropractic Research (PCCR) and the University of Iowa (UI) through the College of Dentistry and the General Clinical Research Center (GCRC) Oral and Craniofacial Unit. The PCCR Clinic and Data Core will serve as the data coordinating center and will develop a web-based data collection system for this project. Patient eligibility will be assessed by dental examiners at the UI College of Dentistry using the Research Diagnostic Criteria for Temporomandibular Disorders to diagnose chronic, Axis I myofascial TMD. Dental care will be provided by a dentist at UI GCRC and chiropractic care will be provided by a private practitioner in close proximity to UI. The aims of this project are to assess the feasibility of conducting a full-scale randomized clinical trial to evaluate the effectiveness of AMCT for patients with chronic myofascial TMD; determine the most appropriate control group(s) for a full-scale randomized controlled trial; and to estimate the sample size needed for an adequately-powered trial and the recruitment period that would be required. In general, there is a lack of evidence for the efficacy of non-surgical treatment for patients with TMD, including chiropractic interventions. If the beneficial effects of the AMCT are supported in this pilot study, the logistical information gained will allow us to plan a full scale trial for patients suffering pain and disability due to TMD. It is anticipated that such a trial will allow clinicians to make more informed recommendations for treatment of patients with TMD. At the conclusion of this project, we will be well-positioned to prepare an R01 level grant application.

Inclusion criteria

• Age 21 years or older
• TMD symptoms for at least 6 months
• Must have 7-8 teeth per dental arch that are in occlusion (can be restored teeth or dental implants with crowns or fixed dental bridgework)
• Typical TMD pain during the past week > = 3 on an 11 point Numerical Rating Scale
• RDC/TMD Axis I diagnosis of myofascial pain (Group Ia or Ib) with or without a concurrent diagnosis of arthralgia (Group IIIa) or disk displacement with reduction (Group IIa)
• Stable prescription medication plan: no changes in prescription medication for pain during the past month

Exclusion criteria

• Current or pending litigation for a personal injury case, worker's compensation, or disability
• Participants with unstable periodontitis and/or a dental condition with untreated disease (e.g., caries). Participants may elect to have her/his dental care provided to stabilize their dental condition prior to randomization.
• Subjects with Canine Class II malocclusion that would prohibit fabrication of RIST appliance
• Cases that need further diagnostic procedures to rule in or rule out the condition (i.e., MRI or CT scan)
• Systemic arthritis or other serious medical condition necessitating maximum daily dosing of COX-2 inhibitor or NSAIDs, (All NSAID use will be recorded in the daily diary as a part of the Self-Care data recording).
• Participants presenting with complete dentures
• Any treatment for TMD during the previous month, except for non-prescription medications or a stable prescription medication regimen for TMD.
• Inability to read or verbally comprehend English
• Unwillingness to be enrolled in any of the four intervention groups.
• Unwillingness to postpone other forms of treatment for TMD during the two month active care phase (except for non-prescription medications or continuation of a stable prescription medication regimen).
• Unwillingness to postpone any chiropractic care during the two month active care phase.
• Intention to move from the area during the next seven months
• Ever had active chiropractor care for TMD pain
• Drug or alcohol abuse
• Pregnant or planning to be pregnant during next seven months
• MVA or other trauma in the last six months
• Facial pain/TMD not worst pain
• General poor health
• Extensive dental work in past 6 months including orthodontics
• Serious co-morbid conditions, including: Lupus Erythematosus, Sjogren's Syndrome, Multiple Sclerosis, Symptomatic Trigeminal Neuralgia (tic/tic douloureux) or any other neuralgia of the face, Thyroid problem not controlled by medication, Uncontrolled diabetes, Rheumatoid arthritis, Fibromyalgia, Polymyalgia Rheumatic, Giant Cell Arteritis, Psoriatic Arthritis, Reiters Syndrome, Bechets Syndrome, Crohn's Disease, Ulcerative Colitis, Parkinson's Disease, Tardive Dyskinesia, Active seizure disorder, Stroke with head and neck symptoms, Addison's Disease, Cushing's Disease
• Have had or ever had any type of head or neck surgery within the last 6 months
• Have had or ever had radiation treatment to the head and/or neck
• Have had or ever had surgery of your jaw joints, not including arthroscopic surgery
• Have had or ever had Herpes Zoster or shingles in the face